UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008480
Receipt number R000009969
Scientific Title A randomised controlled clinical study to evaluate the efficacy and quality of life of structured self glucose monitoring in non-insulin treated type 2 diabetes mellitus patients in Japan
Date of disclosure of the study information 2012/07/20
Last modified on 2017/01/23 11:49:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomised controlled clinical study to evaluate the efficacy and quality of life of structured self glucose monitoring in non-insulin treated type 2 diabetes mellitus patients in Japan

Acronym

Effect on Quality of life and Efficacy of STructured self glucose monitoring in non-insulin treated type 2 diabetes mellitus patients in Japan (QUEST)

Scientific Title

A randomised controlled clinical study to evaluate the efficacy and quality of life of structured self glucose monitoring in non-insulin treated type 2 diabetes mellitus patients in Japan

Scientific Title:Acronym

Effect on Quality of life and Efficacy of STructured self glucose monitoring in non-insulin treated type 2 diabetes mellitus patients in Japan (QUEST)

Region

Japan


Condition

Condition

type 2 diabetes mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In Japan, there has yet been a published study that evaluates the effect of structured self glucose monitoring on glycemic control and quality of life in non-insulin treated type 2 diabetes mellitus patients despite the availability of data from similar studies conducted on non-Japanese patients.
The purpose of the study is to evaluate the effect of self glucose monitoring in a structured manner on glycemic control (as measured by HbA1c) and on quality of life (as scored on the PAID and DTSQ questionnaire) in Japanese patients with type 2 diabetes mellitus and not treated with insulin.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

HbA1c after 6 months and 12months

Key secondary outcomes

glycoalbumin after 6 months and 12months
change of glycoalbumin/HbA1c ratio after 6 months and 12months
change of BMI ratio after 6 months and 12months
change of QOL after 6 months and 12months
frequency and pattern of severe hypoglycemia
frequency and pattern of fasting/postprandial hyperglycemia
opinions against
Accu-Chek® 360 from study subjects and medical stuffs


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment Behavior,custom

Interventions/Control_1

Nutritional consultation three times in first six months and ST-SMBG for a year

Interventions/Control_2

Nutritional consultation three times in first six months without SMBG

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Type 2 diabetes
HbA1c within recent 2 months over 7%

Key exclusion criteria

Already treated by insulin
Already performed SMBG
Who cannot perform SMBG by some reason like dementia
Pregnant
Who have such diseases which affect the values of Hba1c as end-stage renal disease, liver cirrhosis, thyroid disease, and hematological disorders

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shu Meguro

Organization

Keio University school of medicine

Division name

Nephrology, endocrinology, and metabolism department

Zip code


Address

35, Shinanomachi, Shinjuku-ku, Tokyo

TEL

03-3353-1211

Email

shumeg@z8.keio.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shu Meguro

Organization

Keio University school of medicine

Division name

Nephrology, endocrinology, and metabolism department

Zip code


Address

35, Shinanomachi, Shinjuku-ku, Tokyo

TEL

03-3353-1211

Homepage URL


Email

shumeg@z8.keio.jp


Sponsor or person

Institute

Keio University school of medicine, Nephrology, endocrinology, and metabolism department

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 03 Month 31 Day

Date of IRB


Anticipated trial start date

2012 Year 07 Month 01 Day

Last follow-up date

2016 Year 08 Month 31 Day

Date of closure to data entry

2017 Year 01 Month 31 Day

Date trial data considered complete

2017 Year 03 Month 31 Day

Date analysis concluded

2017 Year 05 Month 31 Day


Other

Other related information



Management information

Registered date

2012 Year 07 Month 20 Day

Last modified on

2017 Year 01 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009969


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name